Dr. Michael Burry is betting against Applied Materials while foundry ramps promise to flood equipment suppliers with fresh CapEx. Whether that bearish pressure or the coming demand surge wins out depends on where exactly…
Washington just started writing checks specifically to prevent a Starlink monopoly in orbit, and five U.S.-listed stocks sit directly in the path of that money before the window closes.
TSMC's latest quarter shattered expectations and a fresh $100 billion U.S. commitment signals the chipmaker is betting everything on one unstoppable trend. Whether that bet ends at $437 or $620 hinges on a single…
A late-night tariff pause between the U.S. and Canada left nothing signed and everything at stake, but three stocks are already pricing in a deal that could still fall apart before the ink dries.
Wall Street has quietly built a $1.5 trillion private credit machine that once locked out ordinary investors, but three ETFs now crack open that door in ways most people haven't noticed yet.
iQIYI's core streaming business is shrinking and losses have returned, yet management insists AI-generated content will flip the economics of the entire operation. Whether that bet rescues the stock or drowns it under a…
Social Security alone leaves most retirees scrambling to cover basic expenses, but a carefully constructed portfolio of five monthly dividend payers could change that equation entirely for Baby Boomers sitting on investable savings.
SK Hynix followed the same post-IPO crash pattern as SpaceX and Cerebras, but what happened to its fundamentals during that stumble sets it apart from every other stock in the trillion-dollar club.
Wall Street is firing on all cylinders this Thursday, with major upgrades hitting healthcare, telecom, and e-commerce while Treasury bond buybacks shake up yields and send gold surging past $4,500. Find out which stocks…
Intuit reports fiscal Q4 results on August 25th, and a rare combination of valuation compression, raised guidance, and prediction market conviction is pointing toward a setup that retirement investors may not want to ignore.
Moderna's stock just surged in a way that transforms the company from a cash-burning vaccine maker into a serious acquirer, and four biotech targets already sit within striking range of its newly loaded war…
Trump just signaled the U.S. government could buy Bitcoin at a "sizeable" scale, sending prices past $71,500 and Strategy shares soaring nearly 10%. But a closer look at Strategy's latest moves raises a question…
Alphabet has had a strong year, and a 2X leveraged ETF tracking it sounds like an even better deal until you see the actual returns and realize something quietly eroded a significant chunk of…
A presidential push for crypto legislation sent XRP jumping toward key resistance levels, but whether that political momentum can survive a Senate vote still months away is the question every trader in the room…
A Kentucky family walked away from a life-changing offer for their land, and they are not alone. A wave of resistance is forcing one of the most powerful industries in America to reckon with…
